Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter

Canadian Journal of Cardiology

Volumn 19, Issue 3, 2003, Pages 244-248

  Jalil, Elise ^a   Mensour, Boualem ^a   Vinet, Alain ^a   Kus, Teresa ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Antiarrhythmia; Atrial flutter; Drugs; Re entry

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; PROPAFENONE; SOTALOL;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; ELECTROCARDIOGRAPHY MONITORING; ELECTRODE; EXCITATION AND STIMULATION; FEMALE; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART RIGHT ATRIUM; HUMAN; HYPERTENSION; MALE; MITRAL VALVE STENOSIS; PERICARDITIS; SICK SINUS SYNDROME; DRUG EFFECT; HEART MUSCLE CONDUCTION SYSTEM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PROPAFENONE; RESEARCH DESIGN; SOTALOL; TREATMENT OUTCOME;

EID: 0037444905     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Feld GK, FLeck RP, Chen PS, et al. Radiofrequency catheter ablation for the treatment of human type I atrial flutter: Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992;86:1233-40.
2. Cosio FG, Arribas F, López-Gil M, Goicolea A. Endocardial catheter mapping of atrial arrhythmias. In: Shenasa M, Borgreffe M, Breithardt G, eds. Cardiac Mapping. Mount Kisco: Futura Publishing Co, 1993:443-59.
3. Cosio FG, Arribas F, Lopez-Gil M, Palacios J. Atrial flutter mapping and ablation. I: Studying atrial flutter mechanisms by mapping and entrainment. Pacing Clin Electrophysiol 1996;19:841-53.
4. Nakagawa H, Lazzara R, Khastgir T, et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter: Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation 1996;94:407-24.
5. Strauss HC, Saroff AL, Bigger JT Jr, Giardina EGV. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man: Presentation of data and critical review of the literature. Circulation 1973;47:86-93.
6. Almendral JM, Stamato NJ, Rosenthal ME, Marchlinski FE, Miller JM, Josephson ME. Resetting response patterns during sustained ventricular tachycardia: Relationship to the excitable gap. Circulation 1986;74:722-30.
7. Rosenthal ME, Stamato NJ, Almendral JM, et al. Influence of the site of stimulation on the resetting phenomenon in ventricular tachycardia. Am J Cardiol 1986;58:970-6.
8. Stamato NJ, Rosenthal ME, Almendral JM, Josephson ME. The resetting response of ventricular tachycardia to single and double extrastimuli: Implications for an excitable gap. Am J Cardiol 1987;60:596-601.
9. Stamato NJ, Frame LH, Rosenthal ME, Almendral JM, Gottlieb CD, Josephson ME. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patterns. Am J Cardiol 1989;63:1455-61.
10. Callans DJ, Hook BG, Josephson ME. Comparison of resetting and entrainment of uniform sustained ventricular tachycardia. Further insights into the characteristics of the excitable gap. Circulation 1993;87:1229-38.
11. Sarter BH, Schwartzman D, Callans DJ, Gottlieb CD, Marchlinski FE. Bundle branch reentry ventricular tachycardia: An investigation of the circuit with resetting. J Cardiovasc Electrophysiol 1996;7:1082-5.
12. Della Bella P, Marenzi G, Tondo C, et al. Usefulness of excitable gap and pattern opf resetting in atrial flutter for determining reentry circuit location. Am J Cardiol 1991;6:492-7.
13. Jalil E, Kus T, Le Franc P, Lebeau R, Molin F, Costi P. Effects of procainamide on the excitable gap composition in common human atrial flutter. PACE 1998;21:528-35.
14. Mensour B, Jalil E, Vinet A, Kus T. Influence of propafenone on resetting and termination of canine atrial flutter. PACE 2000;23:1200-19.
15. Naitoh N, Waschizuka T, Takahashi K, Aizawa Y. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing. Jpn Circ J 1998;62:267-73.
16. Masotti CS, Pierangeli A. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: Reversing and preventing as different electrophysiological mechanisms. Panminerva Med 1999;41:295-306.
17. Callans DJ, Hook BG, Josephson ME. The mechanism of propafenone-induced slowing of ventricular tachycardia in man as defined by analysis of resetting response patterns. PACE 1991;14:2035-41.
18. Doni F, Della Bella P, Kheir A, et al. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. Am J Cardiol 1995;76:1243-6.
19. Doni F, Staffiere E, Manfredi M, et al. Type II atrial flutter interruption with transesophageal pacing: Use of propafenone and possible changes of the substrate. PACE 1996;19;1958-61.
20. Cosio FG, Arribas F, Lopez-Gil M, Gonzalez HD. Atrial flutter mapping and ablation II. Radiofrequency ablation of atrial flutter circuits. Pacing Clin Electrophysiol 1996;19:965-75.
21. Fischer B, Haissaguerre M, Garrugues S, et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol 1995;25:1365-72.
22. Schwartzman D, Callans DJ, Gottlieb CD, Dillon SM, Movsowitz C, Marchlinski FE. Conduction block in the inferior vena caval-tricuspid valve isthmus: Association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol 1996;28:1519-31.
23. Ingelmo C, Frame LH. Mechanism for site-dependent differences in the shape of the resetting response curve in fixed barrier reentry. J Cardiovasc Electrophysiol 2000;11:981-9.